Neuralink Targets High-Volume Brain Implant Production by 2026, Musk Confirms

• Neuralink plans "high-volume production" of brain implants and fully automated surgery by 2026, according to Elon Musk.
• The implants are designed to assist people with spinal cord injuries, enabling control of digital devices and online activities.
• Human trials commenced in 2024 after the US Food and Drug Administration approved the application, following an initial rejection in 2022.
• Currently, 12 individuals with severe paralysis have received Neuralink implants, using them to control digital and physical tools with their thoughts.
• The company recently secured $650 million in a June funding round, highlighting strong investment in its technology.

Why It Matters: Neuralink aims for mass production of brain implants by 2026, advancing neurotechnology for paralysis patients.